Butylscopolammonium Bromide
"Butylscopolammonium Bromide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract.
| Descriptor ID |
D002086
|
| MeSH Number(s) |
D02.092.877.310 D02.145.074.722.822.200 D03.132.889.601.200 D03.605.084.500.722.822.200 D03.605.869.822.200
|
| Concept/Terms |
Butylscopolammonium Bromide- Butylscopolammonium Bromide
- Bromide, Butylscopolammonium
- Scopolaminebutylbromide
- Hyoscine N-Butylbromide
- Hyoscine N Butylbromide
- N-Butylbromide, Hyoscine
- N-Butylscopolammonium Bromide
- Bromide, N-Butylscopolammonium
- N Butylscopolammonium Bromide
- Butylscopolamine
- Hyoscinbutylbromide
|
Below are MeSH descriptors whose meaning is more general than "Butylscopolammonium Bromide".
Below are MeSH descriptors whose meaning is more specific than "Butylscopolammonium Bromide".
This graph shows the total number of publications written about "Butylscopolammonium Bromide" by people in this website by year, and whether "Butylscopolammonium Bromide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Butylscopolammonium Bromide" by people in Profiles.
-
Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later. J Pain Symptom Manage. 2018 12; 56(6):902-907.
-
Oral Diclofenac Potassium Versus Hyoscine-N-Butyl Bromide in Reducing Pain Perception during Office Hysteroscopy: ARandomized Double-blind Placebo-controlled Trial. J Minim Invasive Gynecol. 2019 May - Jun; 26(4):709-716.
-
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. Panminerva Med. 2018 Jun; 60(2):65-69.
-
RE: Evaluation of hyoscine N-butyl bromide efficacy on the prevention of catheter-related bladder discomfort after transurethral resection of prostate: a randomized, double-blind control trial. Int Urol Nephrol. 2018 08; 50(8):1445.
-
Hyoscine butylbromide and progress of labor in primigravidae: methodological concerns. J Matern Fetal Neonatal Med. 2019 03; 32(5):876.
-
Comparison of efficacy and safety of hyoscine butylbromide versus anisodamine for acute gastric or intestinal spasm-like pain: A randomized, double-blinded, multicenter Phase III trial. J Dig Dis. 2017 Aug; 18(8):453-460.
-
Lower esophageal sphincter relaxation by administrating hyoscine-N-butylbromide for esophageal impaction by coin - shaped foreign bodies; prospective clinical study in pediatric population. Folia Med Cracov. 2016; 56(4):21-29.